Hirudin as a novel fusion tag for efficient production of lunasin in Escherichia coli

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Preparative Biochemistry & Biotechnology

• Publication date

  2017-02-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/10826068.2017.1286600PMID 28151045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells

  2016cited by this paper
• The Use of Affinity Tags to Overcome Obstacles in Recombinant Protein Expression and Purification.

  2015cited by this paper
• Lunasin as a promising health-beneficial peptide.

  2014cited by this paper
• Recombinant approach for the production of HIV fusion inhibitor Enfuvirtide using Escherichia coli.

  2014cited by this paper
• The Fh8 tag: a fusion partner for simple and cost-effective protein purification in Escherichia coli.

  2013cited by this paper
• Chemopreventive properties of Peptide Lunasin: a review.

  2013cited by this paper
• Structural property of soybean lunasin and development of a method to quantify lunasin in plasma using an optimized immunoassay protocol.

  2013cited by this paper
• Robust preparative-scale extracellular production of hirudin in Escherichia coli and its purification and characterization

  2012cited by this paper
• Recombinant protein expression and purification: A comprehensive review of affinity tags and microbial applications

  2012cited by this paper
• Analysis of lunasin in commercial and pilot plant produced soybean products and an improved method of lunasin purification.

  2012cited by this paper
• Scalable Purification and Characterization of the Anticancer Lunasin Peptide from Soybean

  2012cited by this paper
• Tagging recombinant proteins to enhance solubility and aid purification.

  2011cited by this paper
• An overview of enzymatic reagents for the removal of affinity tags

  2011influential reference
• SUMO fusion technology for enhanced protein expression and purification in prokaryotes and eukaryotes.

  2011cited by this paper
• Designing genes for successful protein expression.

  2011cited by this paper
• Strategies to Optimize Protein Expression in E. coli

  2010cited by this paper
• Carrier proteins for fusion expression of antimicrobial peptides in Escherichia coli

  2009cited by this paper
• Lunasin, a novel seed peptide for cancer prevention.

  2009cited by this paper
• Expression and purification of soluble His(6)-tagged TEV protease.

  2009cited by this paper
• Isolation, purification and characterisation of lunasin from defatted soybean flour and in vitro evaluation of its anti-inflammatory activity

  2009cited by this paper
• Tagging for protein expression.

  2009cited by this paper
• Hydrophobin (HFBI): A potential fusion partner for one-step purification of recombinant proteins from insect cells.

  2008cited by this paper
• Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins.

  2006cited by this paper
• Enhancement of soluble protein expression through the use of fusion tags.

  2006cited by this paper
• Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes

  2006cited by this paper
• Microbial Cell Factories BioMed Central

  2005cited by this paper
• Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli

  2005cited by this paper
• Hydrophobic peptide tags as tools in bioseparation.

  2004cited by this paper
• Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems

  2002cited by this paper
• The P1' specificity of tobacco etch virus protease.

  2002cited by this paper
• Efficient expression and secretion of recombinant hirudin III in E. coli using the L-asparaginase II signal sequence.

  2002cited by this paper
• Current status of the anticoagulant hirudin: its biotechnological production and clinical practice

  2001cited by this paper
• Strategies for achieving high-level expression of genes in Escherichia coli.

  1996cited by this paper
• Gene fusion expression systems in Escherichia coli.

  1995cited by this paper
• Isolation of thrombin inhibitor from the leech Hirudinaria manillensis.

  1991cited by this paper
• Refined structure of the hirudin-thrombin complex.

  1991cited by this paper
• Contribution of the N-terminal region of hirudin to its interaction with thrombin.

  1989cited by this paper
• Amino acid sequence of a soybean (Glycine max) seed polypeptide having a poly(L-aspartic acid) structure.

  1987cited by this paper

• Lunasin: Exploring the pharmacological potential of a soy-derived peptide.

  2025cites this paper
• Strategies to overcome the challenges of low or no expression of heterologous proteins in Escherichia coli.

  2024cites this paper
• Lunasin as a Promising Plant-Derived Peptide for Cancer Therapy

  2022influential citation
• Novel Method for the Production, Purification, and Characterization of Recombinant Lunasin: Identification of Disulfide Cross-Linked Dimers

  2022cites this paper
• Lunasin attenuates oxidant‐induced endothelial injury and inhibits atherosclerotic plaque progression in ApoE−/− mice by up‐regulating heme oxygenase‐1 via PI3K/Akt/Nrf2/ARE pathway

  2019cites this paper
• Current state of art after twenty years of the discovery of bioactive peptide lunasin.

  2019cites this paper
• Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE−/− Mice

  2019cites this paper
• Lunasin functionally enhances LDL uptake via inhibiting PCSK9 and enhancing LDLR expression in vitro and in vivo

  2017cites this paper